7-Acetylintermedine

CAS No. 74243-01-9

7-Acetylintermedine( —— )

Catalog No. M31052 CAS No. 74243-01-9

7-Acetylintermedine is a hepatotoxic botanical pyrrolizidine alkaloid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Acetylintermedine
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Acetylintermedine is a hepatotoxic botanical pyrrolizidine alkaloid.
  • Description
    7-Acetylintermedine is a hepatotoxic botanical pyrrolizidine alkaloid.
  • In Vitro
    7-Acetylintermedine is positive for liver necrosis and possess hepatotoxicity alerts at their pyrroline positions.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    74243-01-9
  • Formula Weight
    341.4
  • Molecular Formula
    C17H27NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sulfo-SMCC sodium

    Sulfo-SMCC sodium is a commonly used hetero-bifunctional, non-cleavable ADC crosslinker bearing N-hydroxysuccinimide (NHS) ester and maleimide groups to react with primary amines and sulfhydryl groups, respectively.

  • Oleanic aldehyde

    Oleanolic aldehyde is an antimicrobial compound used to inhibit oral bacteria. Oleanolic aldehyde inhibits Streptococcus mutans and Porphyromonas gingivalis, which are associated with dental caries and periodontal disease, with minimum inhibitory concentrations (MICs) of 488 μg/mL and 250 μg/mL, respectively.

  • N3-C5-NHS ester

    N3-C5-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).